Basis: Current FMP quote-based enterprise value / four-quarter revenue. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/Sales ratio is N/A as of 2026-10-06T16:38:26.724Z.
Calculation as of: 2026-10-06T16:38:26.724Z.
Quote observation: 2026-10-06T16:35:00.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: e2a68e74349dfba1f638207139de3d6ba43348c68e35092f28537dedf330df9b
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2018-08-10.
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/SALES RATIO
N/A
EV/SALES RATIO AVG TTM
N/A
EV/SALES RATIO AVG 3Y
N/A
EV/SALES RATIO AVG 5Y
N/A
EV/SALES RATIO AVG 10Y
N/A
EV/SALES RATIO AVG 15Y
N/A
EV/SALES RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Market Cap
$5.87M
EV/Sales Ratio
0.06x
TTM Avg
0.10x
3Y Avg
0.09x
5Y Avg
0.46x
Market Cap
$6.06M
EV/Sales Ratio
10.42x
TTM Avg
116.05x
3Y Avg
83.79x
5Y Avg
83.79x
Market Cap
$5.66M
EV/Sales Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$6.04M
EV/Sales Ratio
56.77x
TTM Avg
59.29x
3Y Avg
19360.66x
5Y Avg
791152.03x
| NAME | MARKET CAP | EV/SALES RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| enVVeno Medical Corporation (NVNO) | $5.78M | N/A | N/A | N/A | N/A |
| Lucyd, Inc (LUCY)vs › | $5.80M | 0.99x | 0.52x | 1.80x | 5.65x |
| Sonoma Pharmaceuticals, Inc. (SNOA)vs › | $5.87M | 0.06x | 0.10x | 0.09x | 0.46x |
| Scienture Holdings, Inc. (SCNX)vs › | $6.06M | 10.42x | 116.05x | 83.79x | 83.79x |
| Cuprina Holdings (Cayman) Limited Class A Ordinary Shares (CUPR)vs › | $5.66M | N/A | N/A | N/A | N/A |
| Enlivex Therapeutics Ltd. (ENLV)vs › | $5.94M | N/A | N/A | N/A | N/A |
| Acurx Pharmaceuticals, Inc. (ACXP)vs › | $5.59M | N/A | N/A | N/A | N/A |
| Cardio Diagnostics Holdings, Inc. (CDIO)vs › | $6.04M | 56.77x | 59.29x | 19360.66x | 791152.03x |
| Pulmatrix, Inc. (PULM)vs › | $5.41M | N/A | 974.76x | 727.03x | 628.61x |
| Soligenix, Inc. (SNGX)vs › | $5.34M | N/A | 2.85x | 161.09x | 86.59x |
Enterprise Value (EV) = Market Cap + Total Debt - Cash
Sales = Total Revenue (TTM)
EV/Sales is commonly used because:
Note: EV/Sales does not include margin, debt maturity, cash conversion, or growth durability by itself.
EV/Sales = Enterprise Value / Revenue (TTM)
Enterprise value to sales compares total company value to revenue, useful across capital structures and for unprofitable companies.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EV/SALES RATIO |
|---|---|
| 2018-08-10 | 18.60x |
| 2018-08-09 | 18.75x |
| 2018-08-08 | 18.70x |
| 2018-08-07 | 18.83x |
| 2018-08-06 | 18.93x |
| 2018-08-03 | 18.91x |
| 2018-08-02 | 19.18x |
| 2018-08-01 | 19.29x |
| 2018-07-31 | 19.31x |
| 2018-07-30 | 18.93x |
| 2018-07-27 | 18.94x |
| 2018-07-26 | 18.93x |
| 2018-07-25 | 19.04x |
| 2018-07-24 | 19.24x |
| 2018-07-23 | 19.41x |
| 2018-07-20 | 19.31x |
| 2018-07-19 | 19.31x |
| 2018-07-18 | 19.23x |
| 2018-07-17 | 19.26x |
| 2018-07-16 | 19.29x |
| 2018-07-13 | 19.50x |
| 2018-07-12 | 19.64x |
| 2018-07-11 | 19.96x |
| 2018-07-10 | 19.84x |
| 2018-07-09 | 19.67x |
| 2018-07-06 | 19.74x |
| 2018-07-05 | 19.83x |
| 2018-07-03 | 20.05x |
| 2018-07-02 | 20.00x |
| 2018-06-29 | 20.12x |
| 2018-06-28 | 19.74x |
| 2018-06-27 | 19.80x |
| 2018-06-26 | 20.46x |
| 2018-06-25 | 20.57x |
| 2018-06-22 | 20.77x |
| 2018-06-21 | 20.88x |
| 2018-06-20 | 21.22x |
| 2018-06-19 | 21.04x |
| 2018-06-18 | 21.39x |
| 2018-06-15 | 21.14x |
| 2018-06-14 | 20.98x |
| 2018-06-13 | 20.58x |
| 2018-06-12 | 20.77x |
| 2018-06-11 | 21.06x |
| 2018-06-08 | 21.40x |
| 2018-06-07 | 20.72x |
| 2018-06-06 | 20.83x |
| 2018-06-05 | 21.07x |
| 2018-06-04 | 21.19x |
| 2018-06-01 | 21.45x |
| 2018-05-31 | 21.73x |
